These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2339518)

  • 41. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

  • 42. [Psychophysiological thrombocyte changes in cell-separator donors].
    Aulmann HM; Baltrusch HJ; Stangel W; Waltz EM
    Beitr Infusionther Klin Ernahr; 1987; 18():227-9. PubMed ID: 3439979
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparison of platelet concentrates obtained using blood cell separators with continuous flow: CS-3000 and Cobe-Spectra].
    Dzieciatkowska A; Fusiewicz M; Lachert E; Ziemba-Zółtowska B; Sabliński J
    Acta Haematol Pol; 1994; 25(2):129-34. PubMed ID: 8067183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Storage and transfusion of platelets collected by an automated two-stage apheresis procedure.
    Simon T; Lee EJ; Heaton A; Schiffer CA; Huestis D; Schoendorfer D; Hedberg S; Buchholz D
    Transfusion; 1992 Sep; 32(7):624-8. PubMed ID: 1306649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
    Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
    Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plateletpheresis-induced increase in platelet reactivity using different cell separators.
    Jung F; Bläsi U; Radtke H; Mrowietz C; Pindur G; Kiesewetter H; Wenzel E
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):237-43. PubMed ID: 7496123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of platelet-rich plasma collection using the Haemonetics PCS and Baxter Autopheresis C.
    Anderson NA; Pamphilon DH; Tandy NJ; Saunders J; Fraser ID
    Vox Sang; 1991; 60(3):155-8. PubMed ID: 1862638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modeling of platelet concentrate yield in continuous-flow cell separation devices.
    Hester JP; Ventura GJ
    J Clin Apher; 1988; 4(4):188-93. PubMed ID: 3220820
    [No Abstract]   [Full Text] [Related]  

  • 50. [Mechanical plasmapheresis by means of the Haemonetics-ultralite- plasma collection system: 2. Generation of platelet-rich plasma].
    Richter E; Pawlow I; Matthes G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):127-33. PubMed ID: 1695166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double plateletpheresis (DPA) and tailored RBC collection with the Excel-Pro: preliminary results.
    Valbonesi M; Bruni R; Bo A; De Luigi MC; Stura P; Carlier P; Sanfilippo B
    Transfus Apher Sci; 2001 Feb; 24(1):71-3. PubMed ID: 11515613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High efficiency of CD34+ selection by removal of platelets from the apheresis product.
    Schreiner T; Maccari B; Erne E; Bischof C; Wiesneth M
    Beitr Infusionsther Transfusionsmed; 1997; 34():144-9. PubMed ID: 9356665
    [No Abstract]   [Full Text] [Related]  

  • 53. Automated platelet production during plasmapheresis.
    Rock G; Herzig R; McCombie N; Lazarus HM; Tittley P
    Transfusion; 1983; 23(4):290-3. PubMed ID: 6879667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microparticle content of platelet concentrates is predicted by donor microparticles and is altered by production methods and stress.
    Maurer-Spurej E; Larsen R; Labrie A; Heaton A; Chipperfield K
    Transfus Apher Sci; 2016 Aug; 55(1):35-43. PubMed ID: 27470708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plateletapheresis using single vein access: a comparison of Haemonetics V-50 and Fenwal CS-3000 blood cell separators.
    Vados W; Thompson H; Scott E
    Vox Sang; 1987; 52(3):195-9. PubMed ID: 3604178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of the Trima Accel cell separator in the double dose plateletpheresis.
    Keklik M; Korkmaz S; Kalan U; Sarikoc M; Keklik E
    Transfus Apher Sci; 2016 Oct; 55(2):240-242. PubMed ID: 27522105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viability of platelets collected by apheresis versus the platelet-rich plasma technique: a direct comparison.
    de Vries RA; de Bruin M; Marx JJ; Hart HC; Van de Wiel A
    Transfus Sci; 1993 Oct; 14(4):391-8. PubMed ID: 10146646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation of small volume, leuko and erythrocyte very poor platelet concentrates.
    Valbonesi M; Angelini G; Malfanti L; Lercari G; Fella M; Calderisi S; Anselmo A; Balistreri M
    Int J Artif Organs; 1986 May; 9(3):189-92. PubMed ID: 3733246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.